Engineering of a hemostatic and antibacterial sealant based on oxidized tannic acid-chitosan containing gentamicin sulfate-imprinted tine oxide for surgical adhesives
Bleeding and bacterial infection are major challenges in managing surgical wounds. This study aims to develop a multifunctional nanocomposite sealant based on oxidized tannic acid (OTA)-chitosan containing molecularly imprinted tin oxide nanoparticles (SnO2@MIP) for surgical adhesive applications. S...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Carbohydrate Polymer Technologies and Applications |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666893925001483 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Bleeding and bacterial infection are major challenges in managing surgical wounds. This study aims to develop a multifunctional nanocomposite sealant based on oxidized tannic acid (OTA)-chitosan containing molecularly imprinted tin oxide nanoparticles (SnO2@MIP) for surgical adhesive applications. SnO2@MIP nanoparticles are synthesized using a core-shell approach, with gentamicin sulfate (GS) as the template, methacrylic acid as the functional monomer, and poly(N-isopropyl acrylamide) as a temperature-responsive polymer. The incorporation of 5 wt.% SnO2@MIP into the OTA-chitosan matrix significantly enhances the compressive strength (from 124.3 ± 9.6 kPa to 256.3 ± 16.7 kPa) and modulus (from 73.5 ± 10.3 kPa to 120.0 ± 14.4 kPa) of sealants, attributed to effective hydrogen bonding and cross-linking interactions. Moreover, the addition of SnO2@MIP nanoparticles considerably improves the ex vivo tissue adhesive properties of nanocomposite sealants (103 ± 10 kPa) compared to those of commercialized tissue adhesives. This nanocomposite sealant also demonstrates minimal hemolysis (< 2 %), accelerated blood clotting compared to the control (< 2 min vs. > 6 min), and significant antibacterial properties against Escherichia coli (inhibition zone=17.8 ± 0.6 mm) and Staphylococcus aureus (inhibition zone=26.7 ± 1.6 mm), driven by GS release, reactive oxygen species generated by SnO2, and the intrinsic antibacterial activity of the OTA-chitosan matrix. Nanocomposite sealants could also support the attachment and proliferation of L929 fibroblasts. These findings highlight the potential of SnO2@MIP-loaded chitosan sealants as advanced surgical adhesives with antimicrobial, hemostatic, and drug-release capabilities. |
|---|---|
| ISSN: | 2666-8939 |